SURG SurgePays Forecast, Technical & Fundamental Analysis
Surgepays Inc is a wireless and point of sale technology company focused on serving underserved and value-conscious consumers through a combination of retail distribution and digital acquisition channels... Show more
SURG is expected to report earnings to fall 70.59% to -15 cents per share on August 06
Q2'26
Est.
$-0.15
Q1'26
Missed
by $0.52
Q4'25
Missed
by $0.71
Q3'25
Missed
by $0.26
Q2'25
Missed
by $0.18
The last earnings report on May 15 showed earnings per share of -50 cents, missing the estimate of 0 cents. With 259.66K shares outstanding, the current market capitalization sits at 6.05M.
A.I.dvisor indicates that over the last year, SURG has been loosely correlated with TGL. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if SURG jumps, then TGL could also see price increases.
SURG in downward trend: price dove below 50-day moving average on July 06, 2026
SURG moved below its 50-day moving average on July 06, 2026 date and that indicates a change from an upward trend to a downward trend. In of 43 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on July 15, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SURG as a result. In of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for SURG turned negative on July 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SURG declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
SURG broke above its upper Bollinger Band on July 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for SURG entered a downward trend on July 01, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +5 3-day Advance, the price is estimated to grow further. Considering data from situations where SURG advanced for three days, in of 259 cases, the price rose further within the following month. The odds of a continued upward trend are .
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SURG’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: SURG's P/B Ratio (344.828) is very high in comparison to the industry average of (10.009). P/E Ratio (38.250) is within average values for comparable stocks, (31.386). Projected Growth (PEG Ratio) (0.474) is also within normal values, averaging (10.076). SURG has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.043). P/S Ratio (0.081) is also within normal values, averaging (7.075).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SURG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
